Shots:Chugai Pharmaceutical has entered into a joint research & license agreement with Gero to develop novel therapies for age-related diseasesChugai will develop novel antibody drugs using its proprietary antibody engineering techs for novel targets discovered by Gero's AI target discovery platform, & obtain exclusive global rights to research, develop, manufacture, & commercialize antibodies…